Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Overactivation of STAT Pathways and Overexpression of Survivin Confer Resistance to FLT3 Inhibitors and Could Be Therapeutic Targets in AML.

Jianbiao Zhou, MD, MSc, Chonglei Bi, B.S., Lai Fong Poon, B.S., Viraj J. Janakakumara, B.S., Jiaying Khng, Hanry Yu, Ph.D., Keith B. Glaser, Ph.D., Daniel H. Albert, Ph.D., Davidsen K. Davidsen, Ph.D., Chien-Shing Chen, Ph.D.

Blood (2007) 110 (11): 2367.

https://doi.org/10.1182/blood.V110.11.2367.2367

Published: 2007

Journal Articles

Molecular Analysis of T-Cell Receptor Gene Rearrangements in Children with T-Cell Acute Lymphoblast Leukemia on DFCI ALL Consortium Protocol 95-01.

Aihong Li, MD PhD, Jianbiao Zhou, MD MSc, Hongjun Wang, BS, Meredith A. Goldwasser, ScD, Cheryl Lyons, BA, Stephen E. Sallan, MD, Lewis B. Silverman, MD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 1084.

https://doi.org/10.1182/blood.V104.11.1084.1084

Published: 2004

Journal Articles

Distinct VDJ-H Gene Usage between Mutated and Unmutated Patients in B-CLL: Implications for Pathogenesis and Correlation with Clinical Outcome.

Katja Mauerer, MD, David Zahrieh, MSc, Gullu Gorgun, PhD, Aihong Li, MD PhD, Jianbiao Zhou, MD MSc, Laura Rassenti, PhD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 970.

https://doi.org/10.1182/blood.V104.11.970.970

Published: 2004

Journal Articles

Quantitative Analysis of Minimal Residual Disease at the Completion of Induction Therapy Predicts Relapse in Children with B-Lineage Acute Lymphoblastic Leukemia in DFCI ALL Consortium Protocol 95-01.

Jianbiao Zhou, MD MSc, Aihong Li, MD PhD, Meredith A. Goldwasser, ScD, Hongjun Wang, BS, Virginia Dalton, RN, Cheryl Lyons, BS, Kathryn D. McBride, MPH, Stephen E. Sallan, MD, Lewis B. Silverman, MD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 323.

https://doi.org/10.1182/blood.V104.11.323.323

Published: 2004

Journal Articles

Mapping Low Molecular Weight Plasma Proteome of Chronic Lymphoblastic Leukemia Patients Using MALDI-TOF Mass Spectrometry.

Jianbiao Zhou, MD MSc, Zhinan Xia, PhD, Aihong Li, MD PhD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 1910.

https://doi.org/10.1182/blood.V104.11.1910.1910

Published: 2004

NARROW

Overactivation of STAT Pathways and Overexpression of Survivin Confer Resistance to FLT3 Inhibitors and Could Be Therapeutic Targets in AML.

Molecular Analysis of T-Cell Receptor Gene Rearrangements in Children with T-Cell Acute Lymphoblast Leukemia on DFCI ALL Consortium Protocol 95-01.

Distinct VDJ-H Gene Usage between Mutated and Unmutated Patients in B-CLL: Implications for Pathogenesis and Correlation with Clinical Outcome.

Quantitative Analysis of Minimal Residual Disease at the Completion of Induction Therapy Predicts Relapse in Children with B-Lineage Acute Lymphoblastic Leukemia in DFCI ALL Consortium Protocol 95-01.

Mapping Low Molecular Weight Plasma Proteome of Chronic Lymphoblastic Leukemia Patients Using MALDI-TOF Mass Spectrometry.

Email alerts

ASH Publications

American Society of Hematology

Overactivation of STAT Pathways and Overexpression of Survivin Confer Resistance to FLT3 Inhibitors and Could Be Therapeutic Targets in AML.

Molecular Analysis of T-Cell Receptor Gene Rearrangements in Children with T-Cell Acute Lymphoblast Leukemia on DFCI ALL Consortium Protocol 95-01.

Distinct VDJ-H Gene Usage between Mutated and Unmutated Patients in B-CLL: Implications for Pathogenesis and Correlation with Clinical Outcome.

Quantitative Analysis of Minimal Residual Disease at the Completion of Induction Therapy Predicts Relapse in Children with B-Lineage Acute Lymphoblastic Leukemia in DFCI ALL Consortium Protocol 95-01.

Mapping Low Molecular Weight Plasma Proteome of Chronic Lymphoblastic Leukemia Patients Using MALDI-TOF Mass Spectrometry.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only